Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • gstone
    Junior Member
    • Jan 2017
    • 8

    DESeq2: outlier detection problem

    Please excuse my ignorance as I am new to DESeq2 and differential gene expression analysis in general. Also please excuse the formatting of this post (this is my first post to this forum). I appreciate in advance any and all advice and guidance.

    I am attempting to conduct a paired multi-factor analysis in DESeq2 but I seem to be detecting a lot of differentially expressed genes that are pushed into siginificance due to the presence of an outlier (see attachment of plot of normalized counts). I constructed a PCA plot (attached) and removed the labeled points and re-ran the DESeq2 analysis. I then got no significant genes. I know that DESeq2 has an internal outlier detection and replacement algorithm that requires a specified (I think default is 7) replicates. I have around 200 paired samples, ~100 pre and ~100 post treatment. In accordance with the paired multi-factor DESeq2 vignette, I have structured my sample table like so:

    HTSeq_file sex condition nested
    sample1 Male pre 1
    sample1 Male post 1
    sample2 Male pre 2
    sample2 Male post 2
    sample3 Female pre 1
    sample3 Female post 1
    ... ... ... ...


    When I remove the nested column, which to my understanding is the same as removing pairing, DESeq2 calls its internal filtering and outlier replacing methods. Is the inclusion of pairing making DESeq2 think that I have no replicates? How can I keep my paired design but still take advantage of DESeq2's outlier detection?

    All comments are greatly appreciated.

    Thanks,
    Greg
    Attached Files
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    It looks like your biggest issue is samples that should just be excluded, rather than detecting per-gene outliers.

    Anyway, the outlier detection code only gets called once you have a sufficient number of samples per group. Once you have pairing you'll never hit that, so it'll never get called. I would suggest that you just remove the obviously outlier samples and see if you get more reasonable results.

    Comment

    • gstone
      Junior Member
      • Jan 2017
      • 8

      #3
      That's what I suspected. Thank you very much for your quick response, I appreciate the help.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      46 views
      0 reactions
      Last Post SEQadmin2  
      Working...